EDITORIALS |
1239 | Where to start when treating COPD?
|
1241 | Unravelling the impact of early life exposures on lung structure and function in the developmental origins of asthma
|
1243 | Partitioning strength exercises as an alternative training modality for patients with COPD
|
1245 | Real-time visual-feedback mask-fitting during non-invasive ventilation: A 'technological' gain over 'human' sensing?
|
1247 | Mortality prediction in community-acquired pneumonia: Simplifying reliable tools may be worth it
|
1249 | Connecting insomnia, sleep apnoea and depression
|
1251 | Dissecting the benefits of long-term non-invasive ventilation in patients with distinct neuromuscular disorders
|
INVITED REVIEW SERIES |
Respiratory Sleep Disorders |
1253 | Reviewing the relationship between OSA and cognition: Where do we go from here?
Romola S. Bucks, Michelle Olaithe, Ivana Rosenzweig and Mary J. Morrell
10.1111/resp.13140 |
Seeking Innovative Solutions in Severe Asthma |
1262 | Multidimensional assessment of severe asthma: A systematic review and meta-analysis
Vanessa L. Clark, Peter G. Gibson, Grayson Genn, Sarah A. Hiles, Ian D. Pavord and Vanessa M. McDonald
10.1111/resp.13134 |
Respiratory Infections in the Asia-Pacific Region |
1276 | Pneumonia in the developing world: Characteristic features and approach to management
|
1288 | The respiratory threat posed by multidrug resistant Gram-negative bacteria
|
1300 | A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region
|
SYSTEMATIC REVIEW |
1313 | Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials
Wang-Chun Chen, Chi-Hsien Huang, Chau-Chyun Sheu, Inn-Wen Chong, Kuo-An Chu, Yung-Che Chen, Jong-Rung Tsai, Cheng-Hung Lee and Yu-Feng Wei
10.1111/resp.13100 |
ORIGINAL ARTICLES |
Asthma and Allergy |
1320 | Lung function in relation to farm dwelling and farming activities in rural dwelling children
Lakshmi Balakrishnan, Donna Rennie, James Dosman, Punam Pahwa, Chandima Karunanayake, Louise Hagel and Joshua Lawson
10.1111/resp.13097
We investigated pulmonary function in a rural paediatric Canadian population of farm and non-farm dwelling children. Overall, lung function in both populations was excellent with slightly better lung function in children living on farms. |
1329 | Increased heterogeneity of airway calibre in adult rats after hypoxia-induced intrauterine growth restriction
Kimberley C.W. Wang, Jude S. Morton, Sandra T. Davidge, Alexander N. Larcombe, Alan L. James, Graham M. Donovan and Peter B. Noble
10.1111/resp.13071
Intrauterine growth-restricted individuals have an increased risk of asthma development. The reason for this association is not known. This study used a rat model of intrauterine growth restriction to show persisting structural changes to the airway that has potential implications for bronchoconstriction and disease susceptibility. |
COPD |
1336 | Does limb partitioning and positioning affect acute cardiorespiratory responses during strength exercises in patients with COPD?
Priscila Robles, Tamara Araujo, Dina Brooks, Karl Zabjek, Tania Janaudis-Ferreira, Susan Marzolini, Roger Goldstein and Sunita Mathur
10.1111/resp.13056
Acute cardiorespiratory responses to short bouts of strength exercises may not be affected by the number of limbs engaged; however, responses are greater when arm exercises are performed overhead. This information can assist in the design of upper extremity strength training programmes for patients with COPD. |
Critical Care |
1343 | Randomized crossover trial of a pressure sensing visual feedback system to improve mask fitting in noninvasive ventilation
Anne-Kathrin Brill, Mohammad Moghal, Mary J. Morrell and Anita K. Simonds
10.1111/resp.13074
In a simulated mask-fitting scenario for noninvasive ventilation, real-time visual feedback on pressure exerted over the nasal bridge led to a significantly lower pressure on the face without increase in air leak. The feedback technology improved mask-fitting skills of trained and untrained healthcare professionals. |
Environmental and Occupational Lung Disease |
1350 | Histological variability and consequences in chronic bird-related hypersensitivity pneumonitis
Junichi Ochi, Yoshio Ohtani, Tamiko Takemura, Takumi Akashi, Tomoya Tateishi, Yasunari Miyazaki, Naohiko Inase and Yasuyuki Yoshizawa
10.1111/resp.13070
Spatial histopathological variability and temporal changes of pathology in chronic bird-related hypersensitivity pneumonitis (BRHP) was evaluated. Wide variability in histopathological features was characteristic. Our case series suggests that initial fibrotic nonspecific patterns can later change to bronchiolocentric interstitial pneumonia patterns or usual interstitial pneumonia patterns at autopsy. |
Interstitial Lung Disease |
1357 | Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia
Haruhiko Furusawa, Makiko Sugiura, Chieko Mitaka and Naohiko Inase
10.1111/resp.13054
We evaluated the effectiveness and safety of polymyxin B-immobilized fibre column-direct hemoperfusion (PMX-DHP) treatment for patients with acute exacerbation (AE) of interstitial pneumonia. The results showed that PMX-DHP may improve the prognosis of patients with AE when inducted in the early phase of the exacerbation, especially in patients with dermatomyositis. |
1363 | High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias
Toru Arai, Kazunobu Tachibana, Chikatoshi Sugimoto, Yasushi Inoue, Sayoko Tokura, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi, Seiji Hayashi and Yoshikazu Inoue
10.1111/resp.13065
Multivariate Cox proportional hazard regression analysis revealed that an initial prednisolone (PSL) dose ≥ 0.6 mg/kg is a significant factor for a good prognosis in acute exacerbation of idiopathic interstitial pneumonias without management with positive pressure ventilation. Hence, such doses of PSL may be recommended when commencing treatment. |
1371 |
Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis
Francesco Bonella, Xiaoping Long, Xuan He, Shinichiro Ohshimo, Matthias Griese, Josune Guzman and Ulrich Costabel
10.1111/resp.13082
We evaluated the role of YKL-40, a chitinase-like protein produced by macrophages and epithelial cells, as a biomarker to assess disease activity and outcome in pulmonary alveolar proteinosis (PAP). YKL-40 was elevated in serum and bronchoalveolar lavage fluid (BALF) of PAP patients, and correlated with respiratory impairment and disease outcome.
|
Lung Cancer |
1379 | Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer
Haruki Kobayashi, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo and Toshiaki Takahashi
10.1111/resp.13075
The aim of this study was to estimate the rate of incidence of IPF (idiopathic pulmonary fibrosis)-AE (acute exacerbation) and its prognosis in patients with non-small cell lung cancer (NSCLC) and IPF. The present study suggests that modified gender, age and physiology mGAP index score and stage may predict IPF-AE and its prognosis in patients with NSCLC and IPF. |
Pulmonary Vascular Disease |
1386 |
Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort
Matthew R. Lammi, Lesley A. Saketkoo, Jessica K. Gordon, Paula Lauto, Karen Fagan, Virginia D. Steen and on behalf of the PHAROS Investigators
10.1111/resp.13067
We analysed data for 59 patients with systemic sclerosis-pulmonary hypertension (PH) and an elevated wedge pressure and found that there was no difference in clinical outcomes between those with post-capillary PH and combined pre- and post-capillary PH. The 6-min walk distance was a predictor of death in this group.
|
1393 | CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis
Mitsuaki Yagi, Hiroyuki Taniguchi, Yasuhiro Kondoh, Masahiko Ando, Tomoki Kimura, Kensuke Kataoka, Taiki Furukawa, Atsushi Suzuki, Takeshi Johkoh and Yoshinori Hasegawa
10.1111/resp.13066
In idiopathic pulmonary fibrosis (IPF), the ratio of the diameter of the pulmonary artery to the aorta (PA:A) was significantly correlated with mean pulmonary artery pressure (mPAP). In multivariate analysis, the PA:A, 6-min walk distance (6MWD) and diffusion capacity for carbon monoxide (DLCO) % predicted were independent predictors of mPAP. Moreover, a PA:A > 0.9 was associated with a worse prognosis. |
Respiratory Infections |
1400 | Functional status and mortality prediction in community-acquired pneumonia
Kyeongman Jeon, Hongseok Yoo, Byeong-Ho Jeong, Hye Yun Park, Won-Jung Koh, Gee Young Suh and Eliseo Guallar
10.1111/resp.13072
Premorbid functional status (FS) was independently associated with mortality in unselected patients with community-acquired pneumonia. In addition, adding premorbid FS to the CRB-65 (confusion, respiratory rate, blood pressure and age 65) score showed a significantly and clinically relevant improvement in the predictive ability of CRB-65. |
Sleep and Ventilation |
1407 | Co-morbid OSA and insomnia increases depression prevalence and severity in men
Carol J. Lang, Sarah L. Appleton, Andrew Vakulin, R. Doug McEvoy, Gary A. Wittert, Sean A. Martin, Peter G. Catcheside, Nicholas A. Antic, Leon Lack and Robert J. Adams
10.1111/resp.13064
We investigated the prevalence and clinical profile of previously undiagnosed co-morbid obstructive sleep apnoea (OSA) and insomnia symptoms (COMISA) in men. Men with COMISA have a higher prevalence, and severity, of depressive symptoms than men with OSA or insomnia symptoms alone. This has implications when planning how to identify and treat COMISA in the community. |
1416 | Effects of 1-month withdrawal of ventilatory support in hypercapnic myotonic dystrophy type 1
Fergal J. O'Donoghue, Jean-Christian Borel, Yves Dauvilliers, Patrick Levy, Renaud Tamisier and Jean-Louis Pépin
10.1111/resp.13068
Withdrawal of non-invasive ventilatory support in myotonic dystrophy patients with chronic hypercapnia produced no change in quality of life (QOL) nor somnolence. Small deteriorations were seen in nocturnal oxygenation and daytime CO2 , but without changes in respiratory drive nor lung function. This suggests that the benefits of ventilation support in this group are uncertain. |
Tuberculosis |
1423 | Tuberculosis in China: A longitudinal predictive model of the general population and recommendations for achieving WHO goals
Kaijin Xu, Cheng Ding, Connor J. Mangan, Yiping Li, Jingjing Ren, Shigui Yang, Bing Wang, Bing Ruan, Jifang Sheng and Lanjuan Li
10.1111/resp.13078
We used an eight-state Markov model to predict the tuberculosis (TB) epidemic over 50 years among the general population in China, and we determined the influencing factors and suggested a specific 90-90-90 strategy for TB. Under this strategy, the prevalence would be 1.77 cases per 100,000 population within 50 years. |
POSITION STATEMENTS |
1430 | Spirometry training courses: Content, delivery and assessment - a position statement from the Australian and New Zealand Society of Respiratory Science
Maureen P. Swanney, Christopher A. O'Dea, Emily R. Ingram, Leanne T. Rodwell, Brigitte M. Borg and for the ANZSRS Spirometry Training Course Working Group
10.1111/resp.13133 |
1436 | Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
Helen E. Jo, Lauren K. Troy, Gregory Keir, Daniel C. Chambers, Anne Holland, Nicole Goh, Margaret Wilsher, Sally de Boer, Yuben Moodley, Christopher Grainge, Helen Whitford, Sally Chapman, Paul N. Reynolds, Ian Glaspole, David Beatson, Leonie Jones, Peter Hopkins and Tamera J. Corte
10.1111/resp.13146 |
1459 | The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
Jyotika D. Prasad, Annabelle Mahar, Jane Bleasel, Samantha J. Ellis, Daniel C. Chambers, Fiona Lake, Peter M.A. Hopkins, Tamera J. Corte, Heather Allan and Ian N. Glaspole
10.1111/resp.13163 |
CORRESPONDENCE |
1473 | Should resistance training be targeted to a specific subgroup of patients with non-small cell lung cancer?
|
1474 | Should resistance training be targeted to a specific subgroup of patients with non-small cell lung cancer? – Reply
|